Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Inventory (2020 - 2025)

NeuroPace (NPCE) has 6 years of Inventory data on record, last reported at $16.9 million in Q4 2025.

  • For Q4 2025, Inventory rose 26.27% year-over-year to $16.9 million; the TTM value through Dec 2025 reached $16.9 million, up 26.27%, while the annual FY2025 figure was $16.9 million, 26.27% up from the prior year.
  • Inventory reached $16.9 million in Q4 2025 per NPCE's latest filing, up from $16.3 million in the prior quarter.
  • Across five years, Inventory topped out at $16.9 million in Q4 2025 and bottomed at $7.0 million in Q1 2021.
  • Average Inventory over 5 years is $11.3 million, with a median of $11.0 million recorded in 2023.
  • Peak YoY movement for Inventory: grew 13.21% in 2021, then surged 43.85% in 2025.
  • A 5-year view of Inventory shows it stood at $7.8 million in 2021, then grew by 24.16% to $9.7 million in 2022, then grew by 15.47% to $11.2 million in 2023, then increased by 19.32% to $13.4 million in 2024, then increased by 26.27% to $16.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $16.9 million in Q4 2025, $16.3 million in Q2 2025, and $13.4 million in Q4 2024.